Sandell Asset Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Sandell Asset Management’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-200,000	Closed	-$12M	–	75
2019 Q4	$12M	Buy	+200,000	New	+$7.51M	1.94%	16

Sandell Asset Management's BOLD Position: Q1 2020 in Review

Sandell Asset Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 300,000 shares — an estimated $18M sold.

Sandell Asset Management first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $18M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Sandell Asset Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Sandell Asset Management sold 300,000 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $18M.
Sandell Asset Management first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
Sandell Asset Management's Audentes Therapeutics, Inc position peaked at $18M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Sandell Asset Management's 13F filing for Q1 2020, filed 15 May 2020.